KLEO PHARMACEUTICALS, INC.

Profile

Company Names

KLEO PHARMACEUTICALS, INC.

Addresses

25 SCIENCE PARK, SUITE 2D, 150 MUNSON ST., NEW HAVEN, CT 06511

Phone Numbers

203-691-6332

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$54,141,460.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2018-11-12 
$21,206,378.00 
$21,206,378.00 
$0.00 
Equity 
2
2017-02-28 
$19,403,470.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2016-08-29 
$13,531,612.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
W. 
CHILDS 
DIRECTOR
MATTRESS HOLDINGS, LLC   |  MATTRESS INTERCO INC   |  JWC ACQUISITION CORP.   |  KLEO PHARMACEUTICALS, INC.   |  VERADERMICS, INC
DECLAN 
 
DOOGAN 
DIRECTOR
SPINIFEX PHARMACEUTICALS INC   |  BIOHAVEN PHARMACEUTICAL HOLDING CO LTD.   |  KLEO PHARMACEUTICALS, INC.   |  JUVENESCENCE LTD   |  TENAX THERAPEUTICS, INC.   |  CAUSEWAY THERAPEUTICS LTD
CHARLES 
G. 
DRAKE 
DIRECTOR
KLEO PHARMACEUTICALS, INC.
ALEXANDER 
 
GOOR 
DIRECTOR
DIAMOND TOPCO LTD   |  KLEO PHARMACEUTICALS, INC.
DOUGLAS 
 
MANION 
EXECUTIVE OFFICER, DIRECTOR
KLEO PHARMACEUTICALS, INC.
ROY 
 
PRIEB 
EXECUTIVE OFFICER, DIRECTOR
KLEO PHARMACEUTICALS, INC.   |  CYTOAGENTS, INC.
DAVID 
 
SPIEGEL 
EXECUTIVE OFFICER, DIRECTOR
KLEO PHARMACEUTICALS, INC.   |  QUODDY, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-01-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-12 
2018-05-29
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-29 
2017-05-26
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-29 
2017-05-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#